In addition, avocados enhance the absorption of other carotenoid-rich foods without high fat content, like dark leafy greens, sweet potatoes, and squash, when consumed together
The cardiovascular outcomes data expected from dual GLP-1/amylin therapies offers a great opportunity for differentiation of the product in the market on a basis of greater cardiovascular risk reduction than the current GLP1 monotherapy standards
Here is each
What the Research Shows Recent research on semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has revealed concerning trends about body composition changes: A 2023 analysis of STEP trial data found that approximately 39% of weight lost on semaglutide was lean body mass 1 Research on tirzepatide showed similar patterns, with 30-40% of total weight loss coming from lean tissue 2 Comparative studies indicate GLP-1 users may lose more muscle than people losing weight through diet and exercise alone 3 For context: if you lose 50 pounds on a GLP-1 medication, 15-20 pounds might be muscle mass
Your roots are in science and youre evidence-based
Subsequent reduction with TCEP alongside trapping with excess IAM-TPP generates CAM-S-CAM-TPP from the terminal sulfur atom of RS(S) n S and S(CAM-TPP) 2 from all the internal sulfane sulfur atoms RS(S) n S (Fig